- Expanding access to advanced fracture risk detection
- SimonMed Imaging integrates TBS Osteo™ into DXA scans at more than 80 US locations
- Available now across Arizona, Colorado, Florida, Kentucky, Nevada, and Texas
Geneva, Switzerland — May 1, 2025
Medimaps — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — today announced that SimonMed Imaging has integrated TBS Osteo™ into its DXA scans, enhancing fracture risk assessment for patients across the US. This integration makes TBS® available to more people, supporting better bone health diagnostics.
Why this matters
Osteoporosis affects millions, often going undetected until a fracture occurs. While standard DXA scans measure bone mineral density (BMD), TBS Osteo™ enhances this process by analyzing bone microarchitecture, offering a more comprehensive assessment of fracture risk.
What this means for patients
With TBS Osteo™ now part of SimonMed Imaging‘s DXA scans, patients can benefit from:
- Expanding access to advanced fracture risk detection
- More precise therapy adjustments and ongoing monitoring for osteoporosis
- Optimized patient care through a comprehensive bone health evaluation
SimonMed Imaging has integrated TBS Osteo™ into its DXA scans at more than 80 locations, providing deeper insight into bone health across:
- Arizona
- Colorado
- Florida
- Kentucky
- Nevada
- Texas
"Our partnership with SimonMed is about shifting from reactive to proactive care. By expanding access to advanced diagnostics like TBS, we enable smarter, earlier decisions that prevent fractures and improve outcomes."
said Univ.-Prof. Dr. Didier Hans, CEO and Co-founder of Medimaps.